Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AlloSure Lung Assessment and Metagenomics Outcomes Study

NCT05050955 is registered in ClinicalTrials.gov with CareDx as lead sponsor.

NCT NCT05050955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05050955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AlloSure Lung Assessment and Metagenomics Outcomes Study
Lead sponsor
CareDx
Phase
Observational
Overall status
Active, not recruiting
Start date
October 29, 2021
Completion date
December 31, 2028
Enrollment
550 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant failure and rejection, lung transplant infection, lung transplant; complications